MetLife stock gets a USD 115 Buy target from Jefferies

Published on 10/04/2026 at 20:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

MetLife stock was last at USD 94.43 on October 2, 2026, after a 0.08 percent gain. Q2 adjusted EPS rose 20 percent to USD 2.43.

Isometrische Illustration einer Prozesskette mit Familie, Haus, Auto und Schutzschild — Isometrische 3D-Grafik zeigt die Versicherungs-Wertschöpfungskette, illustrativ und thematisch passend zu MetLife Inc., ISIN US59156R1086, Illustration mit AI erstellt.

MetLife stock (ISIN US59156R1086) was last at USD 94.43 on the NYSE on October 2, 2026, after a 0.08 percent session gain. On October 1, 2026, Jefferies maintained its Buy rating and set a USD 115.00 price target, according to Markets Insider.

Jefferies targets USD 115.00

The Jefferies target stands 21.8 percent above the October 2 price. The rating decision adds a fresh analyst reference point after Piper Sandler raised its target from USD 99.00 to USD 110.00 on September 22, 2026, according to MarketBeat.

MarketBeat also lists a Buy consensus from 12 analysts. The average target is USD 104.31, with a high of USD 111.00 and a low of USD 96.00, putting the average 10.46 percent above the USD 94.43 reference price.

Q3 investment income sets the next test

MetLife estimated at least USD 600 million of pre-tax variable investment income for the quarter ended September 30, 2026. The preliminary figure covers private equity, real estate and other funds plus prepayment fees, according to the company filing reported by StockTitan.

The same filing schedules MetLife's third-quarter earnings release and financial supplement for November 4, 2026. That date gives the preliminary investment-income figure a defined checkpoint, while the final report will show how the estimate translated into earnings.

Second-quarter earnings provide context

For Q2 2026, adjusted earnings rose 15 percent to USD 1.6 billion and adjusted EPS increased 20 percent to USD 2.43. Adjusted return on equity reached 17.0 percent, at the top of MetLife's 15 percent to 17 percent annual target range, according to StockTitan.

Premiums, fees and other revenues grew 7 percent to USD 13.7 billion in that quarter. The combination of higher adjusted earnings and a 17.0 percent adjusted return on equity explains why analyst targets remain above the latest market price, although the Q3 estimate is preliminary.

MetLife stock stays below its yearly high

MetLife stock had a 52-week range of USD 67.33 to USD 100.93 as of October 2, 2026. Its USD 94.43 last price was 6.44 percent below the yearly high, while market capitalization stood at USD 60.8 billion and volume reached 2,974,432 shares.